Lundbeck Loses EU Appeal Over €146M 'Pay For Delay' Fine
The European Union's top court has upheld €146 million ($172 million) in fines imposed on Danish pharmaceutical company Lundbeck and generic drug manufacturers for striking a "pay for delay" agreement over an...To view the full article, register now.
Already a subscriber? Click here to view full article